Warfarin-associated intracerebral hemorrhage

Anna Cavallini, Simona Fanucchi, Alessandra Persico

Research output: Contribution to journalArticlepeer-review


Intracerebral hemorrhage (ICH) is the most serious complication of oral anticoagulant therapy (OAT), with mortality in excess of 50%. Major risk factors are advanced patient age, elevated systolic blood pressure, intensity of anticoagulation, and previous cerebral ischemia. A number of acute treatments are available, but all have significant side effects and no randomized clinical trials assessing clinical outcome have been performed. Future trials will have to address choice and dose of agent, the timing of its administration, and the risk of side effects.

Original languageEnglish
JournalNeurological Sciences
Issue numberSUPPL. 2
Publication statusPublished - Sep 2008


  • Epidemiology
  • Intracerebral hemorrhage
  • Treatment
  • Warfarin

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology


Dive into the research topics of 'Warfarin-associated intracerebral hemorrhage'. Together they form a unique fingerprint.

Cite this